Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1982 Nov;16(5):821–825. doi: 10.1128/jcm.16.5.821-825.1982

Chronic granulomatous disease: fatal septicemia caused by an unnamed gram-negative bacterium.

R A Seger, D G Hollis, R E Weaver, W H Hitzig
PMCID: PMC272483  PMID: 7153335

Abstract

A 2-year-old boy with proven X-linked chronic granulomatous disease was placed under continuous co-trimoxazole prophylaxis. He remained free of infection for 4 years. At age 6.25 years, he suddenly developed a fever with no localizing signs and died 16 days later in septic shock. A gram-negative, catalase-positive, halophilic, aerobic bacterium was cultured from blood, bone marrow, and ascitic fluid. This organism could not be identified in microbiological laboratories in Europe and the United States. Its biochemical features indicate that it may belong to a species which has not previously been described.

Full text

PDF
822

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Gmünder F. K., Seger R. A. Chronic granulomatous disease: mode of action of sulfamethoxazole/trimethoprim. Pediatr Res. 1981 Dec;15(12):1533–1537. doi: 10.1203/00006450-198112000-00017. [DOI] [PubMed] [Google Scholar]
  2. Hitzig W. H., Weber C. Die Progressive Septische Granulomatose. Ergeb Inn Med Kinderheilkd. 1980;44:37–72. [PubMed] [Google Scholar]
  3. Holmes B., Page A. R., Good R. A. Studies of the metabolic activity of leukocytes from patients with a genetic abnormality of phagocytic function. J Clin Invest. 1967 Sep;46(9):1422–1432. doi: 10.1172/JCI105634. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Holmes B., Quie P. G., Windhorst D. B., Good R. A. Fatal granulomatous disease of childhood. An inborn abnormality of phagocytic function. Lancet. 1966 Jun 4;1(7449):1225–1228. doi: 10.1016/s0140-6736(66)90238-8. [DOI] [PubMed] [Google Scholar]
  5. Holmes B., Quie P. G., Windhorst D. B., Pollara B., Good R. A. Protection of phagocytized bacteria from the killing action of antibiotics. Nature. 1966 Jun 11;210(5041):1131–1132. doi: 10.1038/2101131a0. [DOI] [PubMed] [Google Scholar]
  6. Johnston R. B., Jr, Baehner R. L. Chronic granulomatous disease: correlation between pathogenesis and clinical findings. Pediatrics. 1971 Nov;48(5):730–739. [PubMed] [Google Scholar]
  7. Klebanoff S. J., White L. R. Iodination defect in the leukocytes of a patient with chronic granulomatous disease of childhood. N Engl J Med. 1969 Feb 27;280(9):460–466. doi: 10.1056/NEJM196902272800902. [DOI] [PubMed] [Google Scholar]
  8. Kobayashi Y., Amano D., Ueda K., Kagosaki Y., Usui T. Treatment of seven cases of chronic granulomatous disease with sulfamethoxazole-trimethoprim (SMX-TMP). Eur J Pediatr. 1978 Apr 20;127(4):247–254. doi: 10.1007/BF00493540. [DOI] [PubMed] [Google Scholar]
  9. Lazarus G. M., Neu H. C. Agents responsible for infection in chronic granulomatous disease of childhood. J Pediatr. 1975 Mar;86(3):415–417. doi: 10.1016/s0022-3476(75)80975-9. [DOI] [PubMed] [Google Scholar]
  10. Mandell G. L., Hook E. W. Leukocyte bactericidal activity in chronic granulomatous disease: correlation of bacterial hydrogen peroxide production and susceptibility to intracellular killing. J Bacteriol. 1969 Oct;100(1):531–532. doi: 10.1128/jb.100.1.531-532.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Riley P. S., Tatum H. W., Weaver R. E. Pseudomonas putrefaciens isolates from clinical specimens. Appl Microbiol. 1972 Nov;24(5):798–800. doi: 10.1128/am.24.5.798-800.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. West M., Burdash N. M., Freimuth F. Simplified silver-plating stain for flagella. J Clin Microbiol. 1977 Oct;6(4):414–419. doi: 10.1128/jcm.6.4.414-419.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Whitin J. C., Chapman C. E., Simons E. R., Chovaniec M. E., Cohen H. J. Correlation between membrane potential changes and superoxide production in human granulocytes stimulated by phorbol myristate acetate. Evidence for defective activation in chronic granulomatous disease. J Biol Chem. 1980 Mar 10;255(5):1874–1878. [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES